logo

Passion for Innovation. Compassion for Patients.™

Daiichi Sankyo Europe GmbH

Take a New Challenge for Drug Discovery (TaNeDS) Europe 2017

This open competition grant program, initiated by Daiichi Sankyo Global, is a joint drug discovery initiative for universities and research institutes, aiming to increase collaborative opportunities. The program is open to principal investigators affiliated with research institutions in academia and small biotech located in Europe.

In 2011, the initiative was originally launched in Japan to help discover new lines of research through open innovation. From 2013 onwards, the global drug discovery program has expanded outside of Japan.

All EU member states plus Iceland, Norway, Switzerland and Israel are eligible to participate in this program and may conduct research. Participants are selected by matching Daiichi Sankyo's research interests as well as demonstrating originality, potentiality and possibility of drug discovery.

The TaNeDS program provides close partnership between you and scientists at Daiichi Sankyo to tackle unmet medical needs.

A variety of research themes is covered: on this page you will find more info about our research interests.

The deadline of submission for 2017 has already passed (20 February 2017). More info about eligibility, funding size, the application form and more here.

We are already excited to see which topics will be selected in 2017 - innovation in the making!